BridgeMD
New treatment option for Smoking Cessation
Official title Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS
ClinicalTrials.gov ID: NCT05746442
What this study is testing
What is Nicotine patch?
Nicotine patch is an investigational medicine, being studied as a potential treatment for smoking cessation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this research study is to test how well an automated text messaging smoking treatment program helps smokers with HIV quit smoking.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1) being aged ≥18 years
- 2) being HIV-positive
- 3) self-reporting as a current combustible cigarette smoker (smoked ≥100 cigarettes in lifetime and currently smoke ≥1 cigarettes/day)
- 4) willing to set a date for a quit attempt within 2 weeks of study enrollment
- 5) being able to provide written informed consent to participate
You likely can't join if
- 1) history of a medical condition that precludes use of nicotine replacement therapy
- 2) physician/clinician deemed ineligible to participate based on medical or psychiatric condition
- 3) enrolled in another cessation program or use of other cessation medications.
See the full eligibility criteria
- 1) being aged ≥18 years
- 2) being HIV-positive
- 3) self-reporting as a current combustible cigarette smoker (smoked ≥100 cigarettes in lifetime and currently smoke ≥1 cigarettes/day)
- 4) willing to set a date for a quit attempt within 2 weeks of study enrollment
- 5) being able to provide written informed consent to participate
- 6) being able to read Khmer (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form
- 1) history of a medical condition that precludes use of nicotine replacement therapy
- 2) physician/clinician deemed ineligible to participate based on medical or psychiatric condition
- 3) enrolled in another cessation program or use of other cessation medications.
The study team makes the final eligibility decision.
Where it's taking place
- Phnom Penh, Cambodia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phnom Penh, Cambodia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.